Julie Ramage

National Account Director, Diagnostics, Pfizer Oncology

With over 23 years of experience in the lab industry, working for many large commercial labs in Management of Sales related roles, Julie joined Pfizer Oncology five years ago to provide subject matter expertise to their growing portfolio of therapies with companion diagnostic activities. With expansive background in pathology, technologies, platforms, reimbursement and regulatory matters, Julie has also become one of Pfizer Oncology’s primary experts in data aggregation, purchase, and evaluation within the business unit in regards to biomarkers. Julie also serves on the Board of Directors for the California Clinical Lab Association as their previous president and now as the Secretary of the board. She is involved in many organizations such as Precision Medicine Coalition, and patient advocacy groups.

Julie is speaking at

October 24, 2018
8:00 am - 3:30 pm
Columbia B

Speakers

  • Beth Bailey (Speaker) Director, Strategic Development, TriCore Reference Laboratories
  • Lisa Jean Clifford (Speaker) COO & Chief Strategy Officer, Gestalt Diagnostics
  • Linda Smith (Speaker) Vice President, Laboratory Services, SSM Health
  • Steve Stonecypher (Speaker) Partner, Shipwright Healthcare Group
  • Barb Senters (Speaker) Chief Compliance & Ethics Officer, Sonic Healthcare USA
  • James M Crawford, MD, PhD (Speaker) Chair, Department of Pathology and Laboratory Medicine / Senior Vice President Laboratory Services, Zucker School of Medicine, Hofstra/Northwell / Northwell Health System
  • Patricia Goede (Speaker) VP Clinical Informatics, XIFIN, Inc.
  • Julie Ramage (Speaker) National Account Director, Diagnostics, Pfizer Oncology
  • Shally Madan (Speaker) Co-founder & COO, LuminateHealth

Description

What does FutureLab look like? What does your lab need to focus on to be ready to operate in a Clinical Lab 2.0 environment?

In this one-day interactive Summit, strategic planning experts and lab leaders will guide attendees step-by-step through the process of connecting trends to trajectories and developing a competitive roadmap for your diagnostic lab using Clinical Lab 2.0 ideology.

In the morning sessions, we’ll conduct an external scan and learn about the market opportunities and threats facing laboratories, such as new customers, alternative markets and revenue streams, the compliance/legal environment, and non-traditional competition. We’ll also explore emerging FutureLab technology and innovation, such as artificial intelligence and innovation in pathology.

In the afternoon, we’ll do an internal scan. Attendees will learn how to assess their own labs’ strengths and weaknesses to defend against the threats and to maximize the opportunities. And finally, we’ll connect the dots and target specific strategies you need to become a successful FutureLab. You’ll walk away with a practical Clinical Lab 2.0 toolbox to facilitate future planning.

Session Objectives:

  • Engage subject matter experts to explore external market opportunities and threats in order to paint a canvas of FutureLab;
  • Target your FutureLab opportunities based on your lab’s strengths; begin to understand your lab’s possible gaps in FutureLab; and
  • Determine action steps and target additional learning at Lab Institute 2018.

Add to my calendar

Add to Google Add to Outlook (.ics)

Create your personal schedule through the official app, Whova!

Get Started